Case Studies

Through a series of case studies, you can explore examples of changes that allow efficient delivery of molecular radiotherapy services around the needs of patients. All cases describe GB initiatives optimising the management of patients with NETs receiving molecular radiotherapy.

Click on the links below to download PDF files of individual case studies.

AAA-Lu177-UK-2236 | October 2023

Introduction

Introduction to the need for the NHS to embrace change for delivery of molecular radiotherapy services, the importance of patient-centred care, and available treatments.

AAA-Lu177-UK-2232 | October 2023

Exploring Potential Service Options

A series of step-by-step guides to explore service options, including information on the redesign process, key stakeholders for successful implementation and a template action plan to facilitate the change process.

AAA-Lu177-UK-2233 | October 2023

Implementation Resources

Editable resources to support initial and follow-up meetings with colleagues, create a business case for service development, and an action plan to capture outputs from implementation meetings.

AAA-Lu177-UK-2234 | October 2023

Starter Pack

Guidance and resources on setting up a delivery service for Lutathera^® for patients with neuroendocrine tumours (NETs), including service set-up, Lutathera^® information, including product administration, and information on patient management.

AAA-Lu177-UK-2196 | December 2023

Image of person teaching a class of adult students.

PRRT Masterclass Videos 2021

Browse the catalogue of videos from the 2021 PRRT Masterclass sessions.

AAA-Lu177-UK-2161 | October 2023

PRRT Masterclass Videos

PRRT Masterclass Videos 2020

Browse our catalogue of videos and watch experts in the field of NETs discuss their clinical insights on the evidence for the diagnosis, management and treatment of NETs, with a focus on PRRT.

AAA-Lu177-UK-2162 | October 2023

Update from ECE 2021

Watch the Advanced Accelerator Applications satellite symposium from the 23^rd European Congress of Endocrinology (ECE) virtual congress, "Timing is everything: Early intervention with LUTATHERA^® (lutetium [177Lu] oxodotreotide) following progression in

AAA-Lu177-UK-2006 | June 2023

Treatment Guidelines

Stay up to date with the current evidence-based and expert consensus guidelines for GEP-NETs.

AAA-Lu177-UK-2149 | October 2023

Image of a female doctor speaking to a patient while sitting at her desk.

Identifying Progression

Monitoring patients for signs of progression is an essential but sometimes challenging process.

AAA-Lu177-UK-2148 | October 2023

Disease Background

Find easy-to-digest materials, which will provide you with an overview of NETs, covering incidence and presentation through to diagnosis and treatment.

AAA-Lu177-UK-2147 | October 2023